14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      The Neurostimulation Appropriateness Consensus Committee (NACC) Recommendations for Infection Prevention and Management : The Neurostimulation Appropriateness Consensus Committee

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d2610646e358">The use of neurostimulation for pain has been an established therapy for many decades and is a major tool in the arsenal to treat neuropathic pain syndromes. Level I evidence has recently been presented to substantiate the therapy, but this is balanced against the risk of complications of an interventional technique. </p>

          Related collections

          Most cited references137

          • Record: found
          • Abstract: not found
          • Article: not found

          Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Treatment of infections associated with surgical implants.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Preventing surgical-site infections in nasal carriers of Staphylococcus aureus.

              Nasal carriers of Staphylococcus aureus are at increased risk for health care-associated infections with this organism. Decolonization of nasal and extranasal sites on hospital admission may reduce this risk. In a randomized, double-blind, placebo-controlled, multicenter trial, we assessed whether rapid identification of S. aureus nasal carriers by means of a real-time polymerase-chain-reaction (PCR) assay, followed by treatment with mupirocin nasal ointment and chlorhexidine soap, reduces the risk of hospital-associated S. aureus infection. From October 2005 through June 2007, a total of 6771 patients were screened on admission. A total of 1270 nasal swabs from 1251 patients were positive for S. aureus. We enrolled 917 of these patients in the intention-to-treat analysis, of whom 808 (88.1%) underwent a surgical procedure. All the S. aureus strains identified on PCR assay were susceptible to methicillin and mupirocin. The rate of S. aureus infection was 3.4% (17 of 504 patients) in the mupirocin-chlorhexidine group, as compared with 7.7% (32 of 413 patients) in the placebo group (relative risk of infection, 0.42; 95% confidence interval [CI], 0.23 to 0.75). The effect of mupirocin-chlorhexidine treatment was most pronounced for deep surgical-site infections (relative risk, 0.21; 95% CI, 0.07 to 0.62). There was no significant difference in all-cause in-hospital mortality between the two groups. The time to the onset of nosocomial infection was shorter in the placebo group than in the mupirocin-chlorhexidine group (P=0.005). The number of surgical-site S. aureus infections acquired in the hospital can be reduced by rapid screening and decolonizing of nasal carriers of S. aureus on admission. (Current Controlled Trials number, ISRCTN56186788.) 2010 Massachusetts Medical Society
                Bookmark

                Author and article information

                Journal
                Neuromodulation: Technology at the Neural Interface
                Neuromodulation: Technology at the Neural Interface
                Wiley-Blackwell
                10947159
                January 2017
                January 02 2017
                : 20
                : 1
                : 31-50
                Article
                10.1111/ner.12565
                28042909
                3c3f0d52-0cbc-41bd-834a-312607ab84a6
                © 2017

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article